# S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

> **NCT00045630** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 77 (actual)

## Conditions studied

- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- Urethral Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** gemcitabine
- **DRUG:** paclitaxel
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT00045630
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2008-05
- **Final completion:** 2011-12
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2013-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045630, "S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00045630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*